Combined detection of circulating tumor cells, α-fetoprotein heterogene-3 and α-fetoprotein in the early diagnosis of HCC for the prediction of efficacy, prognosis, recurrence after microwave ablation

Table 7 Analysis of the Relationship between Serum AFP, AFP-L3, CTCs Levels and Short-term Efficacy after Microwave Ablation in HCC Patients

Group	Time	Cases	AFP(ng/mL)	AFP-L3(%)	CTCs
CR+PR	Before surgery	69	172.44(67.93~612.09)	15.36(13.87~16.37)	2.30(1.95~2.61)
CR+PR	3 months after surgery	69	54.38(30.25~89.51)^a	6.68(4.92~8.15)^a	1.63(1.49~1.88)^a
SD+PD	Before surgery	36	264.51(117.87~731.85)^a	18.53(16.20~19.26)^a	2.64(2.22~2.93)^a
SD+PD	3 months after surgery	36	326.82(193.20~437.36)^ab	20.91(18.65~23.51)^ab	2.95(2.54~3.21)^ab

Note: Compared with CR + PR group before surgery, ^aP<0.05; compared with CR + PR group 3 months after surgery, ^bP<0.05

ISSN: 1750-9378